Doss, Manoj K.
May, Darrick G.
Johnson, Matthew W.
Clifton, John M.
Hedrick, Sidnee L.
Prisinzano, Thomas E.
Griffiths, Roland R.
Barrett, Frederick S.
Funding for this research was provided by:
National Institute on Drug Abuse (T32DA007209, T32DA007209, R01DA018151, R01DA03889)
Article History
Received: 14 February 2020
Accepted: 11 September 2020
First Online: 2 October 2020
Competing interests
: M.W.J. has served as a paid consultant for Entheogen Biomedical and Otsuka Pharmaceutical regarding medications development related to psychedelic compounds. R.R.G. is a board member of the Heffter Research Institute. M.K.D., D.G.M., J.M.C., S.L.H., T.E.P., and F.S.B. have no competing interests to declare.